Urges federal government to establish WIC waiver program allowing states to authorize use of WIC benefits to purchase alternative infant formulas during public emergencies.
Assembly Resolution 142 is a nonbinding federal-advocacy resolution urging the U.S. Department of Agriculture’s Food and Nutrition Service to create a permanent WIC waiver program for public emergencies. The proposed waiver would let state WIC agencies quickly authorize participants to buy alternative brands, formulations, and quantities of infant formula when normal supply chains are disrupted. The resolution is framed around the infant formula shortages experienced during the COVID-19 pandemic and the 2022 recall and production shutdowns, which made it difficult for families to obtain formula through standard WIC purchasing rules.
The resolution explains that WIC participants are ordinarily limited to formula products selected through state contracts, but emergency waivers previously allowed more flexibility. AR142 argues that a standing waiver mechanism would help states respond faster in future crises and ensure infants continue to receive needed nutrition. It also highlights that many WIC participants rely on formula, including families unable to breastfeed for medical, practical, or adoption-related reasons.
AR142 would not change New Jersey statutes or create a state program; instead, it expresses the General Assembly’s position and transmits that request to federal officials and Congress. Its practical impact is to advocate for federal administrative action that would give state WIC agencies greater flexibility during emergencies to approve substitute infant formulas for eligible participants. If adopted federally, the policy could affect WIC vendors, state nutrition administrators, formula manufacturers, and low-income families with infants who depend on WIC benefits.
The overall sentiment is supportive and protective of infant and family nutrition. The resolution reflects concern about the hardships caused by formula shortages and a desire to preserve access for vulnerable infants during future emergencies. The discussion embedded in the text is strongly favorable toward maintaining emergency flexibility and preventing a repeat of the disruptions seen during the pandemic and recall period.
There is little direct contention in the bill text or available legislative history, since the measure is a resolution urging federal action rather than imposing state mandates. The main policy issue is whether WIC should continue to rely on tightly controlled formula contracting or instead have a permanent emergency waiver process that allows broader product substitutions. Any tension would likely be between maintaining standard procurement rules and giving states faster, more flexible authority during supply crises; the resolution clearly sides with flexibility.